AN AUDIT TO EVALUATE THE EFFECTIVENESS OF INTRAVENOUS HEMATINICS THERAPY IN PERIOPERATIVE OUTCOMES IN MAJOR ABDOMINAL ONCOSURGERIES

Anemia, a condition where the blood lacks enough healthy red blood cells to carry oxygen, is common in cancer patients scheduled for major abdominal surgeries. It affects 30–60% of these patients and can lead to complications such as increased need for blood transfusions, delayed recovery, and longer hospital stays. Traditional treatments like oral iron supplements often fail to address this anemia effectively because cancer and related conditions interfere with how the body processes and uses iron.

This study aims to explore the use of intravenous (IV) iron therapy to treat anemia before surgery. Unlike oral supplements, IV iron bypasses the barriers caused by inflammation and allows for faster correction of anemia. By improving hemoglobin before surgery, we hope to reduce the need for blood transfusions during or after the operation, lower the risk of complications, and speed up recovery.

Over one year, we will monitor cancer patients undergoing elective abdominal surgeries at our hospital. We will examine how effective IV iron therapy is in improving hemoglobin levels, reducing blood transfusions, and ensuring better overall outcomes. This research is especially important in countries like India, where anemia is highly prevalent, and effective management could significantly improve peri-operative outcomes.